-transparent.png){kind=logo}
A patient is described in whom CML first presented as blastic crisis. The diagnosis of CML was based upon the findings of Ph(1) chromosome in the bone marrow, basophilia in the peripheral blood, absence of NAP activity in the leukocytes, elevated serum vitamin B(12) and an enlarged firm spleen. CML with blastic crisis as its first expression is relatively rare, as compared to CML in which blastic crisis appears as a phase of prolonged clinically manifest disease.
Related Publications
U Mintz, and
S Bar-Meir, and
J Pinkhas, and
A De Vries
October 1972,
Cancer,
U Mintz, and
S Bar-Meir, and
J Pinkhas, and
A De Vries
January 1991,
Haematologica,
U Mintz, and
S Bar-Meir, and
J Pinkhas, and
A De Vries
January 1984,
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer,
U Mintz, and
S Bar-Meir, and
J Pinkhas, and
A De Vries
November 1984,
Cancer treatment reports,
U Mintz, and
S Bar-Meir, and
J Pinkhas, and
A De Vries
July 1992,
The Tokai journal of experimental and clinical medicine,
U Mintz, and
S Bar-Meir, and
J Pinkhas, and
A De Vries
January 1969,
Neoplasma,
U Mintz, and
S Bar-Meir, and
J Pinkhas, and
A De Vries
January 2005,
Acta haematologica,
U Mintz, and
S Bar-Meir, and
J Pinkhas, and
A De Vries
October 1979,
Pediatric radiology,
U Mintz, and
S Bar-Meir, and
J Pinkhas, and
A De Vries
June 1989,
Cancer genetics and cytogenetics,
U Mintz, and
S Bar-Meir, and
J Pinkhas, and
A De Vries
May 2006,
Current treatment options in oncology,
